Cone E J, Tsadik A, Oyler J, Darwin W D
Addiction Research Center, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA.
Ther Drug Monit. 1998 Oct;20(5):556-60. doi: 10.1097/00007691-199810000-00019.
Cocaine abusers frequently self-administer cocaine by different routes of administration. A controlled-dosing study was performed to assess the effect of different routes of administration on the excretion profile of cocaine and metabolites in urine. Single bioequivalent doses of cocaine were administered by the intravenous, intranasal, and smoked routes to six human subjects. Urine specimens were collected for 3 days after drug administration and were analyzed for cocaine, metabolites, and anhydroecgonine methyl ester, the thermal degradation product of cocaine, by gas chromatography-mass spectrometry. Cocaine was rapidly absorbed, metabolized, and excreted in urine. Peak cocaine concentrations were generally present in the first specimen collected; thereafter, concentrations declined quickly and were usually below the limit of detection (approximately 1 ng/ml) within 24 hours. The metabolite benzoylecgonine was present in the highest concentration and represented approximately 39%, 30%, and 16%, of the administered dose by the intravenous, intranasal, and smoked routes, respectively. Combined amounts of ecgonine methyl ester and six minor metabolites (norcocaine, benzoylnorecgonine, m-hydroxycocaine, p-hydroxycocaine, m-hydroxybenzoylecgonine, and p-hydroxybenzoylecgonine) accounted for approximately 18%, 15%, and 8% of the administered dose by the intravenous, intranasal, and smoked routes, respectively. Anhydroecgonine methyl ester was present in trace amounts (0.02% dose) in specimens collected after smoked cocaine administration. Because many of these metabolites exhibit pharmacologic activity, their presence in urine may indicate that they play complex biologic roles in the overall activity of cocaine.
可卡因滥用者经常通过不同给药途径自行使用可卡因。进行了一项控制剂量研究,以评估不同给药途径对可卡因及其代谢物在尿液中排泄情况的影响。向6名人类受试者分别通过静脉注射、鼻内给药和吸食途径给予单剂量生物等效的可卡因。给药后3天收集尿液样本,并用气相色谱 - 质谱法分析其中的可卡因、代谢物以及可卡因的热降解产物脱水芽子碱甲酯。可卡因在尿液中迅速被吸收、代谢和排泄。可卡因浓度峰值通常出现在采集的首个样本中;此后,浓度迅速下降,通常在24小时内降至检测限(约1纳克/毫升)以下。代谢物苯甲酰芽子碱浓度最高,静脉注射、鼻内给药和吸食途径分别约占给药剂量的39%、30%和16%。芽子碱甲酯和六种次要代谢物(去甲可卡因、苯甲酰去甲芽子碱、间羟基可卡因、对羟基可卡因、间羟基苯甲酰芽子碱和对羟基苯甲酰芽子碱)的总量,静脉注射、鼻内给药和吸食途径分别约占给药剂量的18%、15%和8%。吸食可卡因后采集的样本中脱水芽子碱甲酯含量微量(占剂量的0.02%)。由于这些代谢物中的许多都具有药理活性,它们在尿液中的存在可能表明它们在可卡因的整体活性中发挥着复杂的生物学作用。